OpenFilings

Jasper Therapeutics, Inc.

Form8-K/A

Report Period2026-07-16

Date Filed2026-10-01

Time Filed17:29:23

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

AMENDMENT NO. 1 TO FORM 8-K
CONSENT OF EISNERAMPER LLP, INDEPENDENT AUDITORS OF KIRA PHARMACEUTICALS
AUDITED FINANCIAL STATEMENTS OF KIRA PHARMACEUTICALS AS OF DECEMBER 31, 2025 AND
UNAUDITED FINANCIAL STATEMENTS OF KIRA PHARMACEUTICALS AS OF JUNE 30, 2026 AND F
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF JASPER THERAPEUT
Filing on SEC Edgar